跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEDAGA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEDAGA
Authorized
STANDARD
LEDAGA
recordati rare diseases canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a505c1d4edab894d
Company
recordati rare diseases canada inc
Type
Standard
Approval Details
Approval Id
a505c1d4edab894d
Drug Approval Canada Name
LEDAGA
Product Name
LEDAGA
Status
Marketed
Status Date
2022-09-14
Original Market Date
2022-09-14
Din
02516764
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AA05 CHLORMETHINE
Atc Name
l 01 aa 05
Aig Number
0107722002
Company Name
recordati rare diseases canada inc
Company Address
3080 Yonge Street, Suite 6060, Toronto, Ontario, Canada, M4N 3N1
Active Ingredients
CHLORMETHINE (CHLORMETHINE HYDROCHLORIDE)
160 MCG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a505c1d4edab894d
Type
Standard
Back to Health Canada Approvals